COMMUNIQUÉS West-GlobeNewswire

HMS Settles Litigation Related To 2010 Asset Purchase - Agreement Substantially Reduces 2017 Jury Award
02/07/2018
IRVING, Texas, July 02, 2018 (GLOBE NEWSWIRE) -- HMS Holdings Corp. (Nasdaq:HMSY) today announced that it has reached a settlement agreement in litigation pending in the Supreme Court of New York. The case related to [...]
Kura Oncology Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares
02/07/2018
SAN DIEGO, July 02, 2018 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq:KURA), a clinical-stage biopharmaceutical company focused on the development of precision medicines for oncology, today announced the closing of [...]
NeoGenomics Schedules its Second Quarter Earnings Release for July 24, 2018
02/07/2018
FT. MYERS, Fla., July 02, 2018 (GLOBE NEWSWIRE) -- NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services, announced today that it plans to release its second quarter 2018 [...]
Zafgen Announces Closing of Offering of Common Stock and Exercise in Full of the Underwriters’ Option to Purchase Additional Common Shares
02/07/2018
BOSTON, July 02, 2018 (GLOBE NEWSWIRE) -- Zafgen, Inc., (Nasdaq:ZFGN), a clinical-stage biopharmaceutical company leveraging its proprietary MetAP2 biology platform to develop novel therapies for patients affected by [...]
TiGenix: Transparency Information
02/07/2018
PRESS RELEASE REGULATED INFORMATION Transparency Information Leuven (Belgium) - July 2, 2018, 22:00h CET - TiGenix NV (Euronext Brussels and Nasdaq: TIG) publishes information in accordance with articles 15 and 18 of [...]
Align Technology to Announce Second Quarter 2018 Results on July 25, 2018
02/07/2018
SAN JOSE, Calif., July 02, 2018 (GLOBE NEWSWIRE) -- Align Technology, Inc. (Nasdaq:ALGN) announced today that the Company will report second quarter 2018 financial results on Wednesday, July 25, 2018 after the close of [...]
OncBioMune Signs Work Order for Phase 2 Clinical Trial of ProscaVax for Early Stage Prostate Cancer
02/07/2018
BATON ROUGE, La., July 02, 2018 (GLOBE NEWSWIRE) -- OncBioMune Pharmaceuticals, Inc. (OTCQB:OBMP) ("OncBioMune" or the "Company"), a clinical-stage biopharmaceutical company engaged in the development of a proprietary [...]
Summit Therapeutics plc : Holding(s) in Company
02/07/2018
TR-1: S tandard form for notification of major holdings 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii : SUMMIT THERAPEUTICS PLC 1b. Please indicate if the [...]
Summit Therapeutics plc : Holding(s) in Company
02/07/2018
TR-1: S tandard form for notification of major holdings 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii : SUMMIT THERAPEUTICS PLC 1b. Please indicate if the [...]
Alzheimer’s Foundation of America Awards College Scholarships to Students Impacted by Alzheimer’s Disease
02/07/2018
NEW YORK, July 02, 2018 (GLOBE NEWSWIRE) -- The Alzheimer’s Foundation of America recently awarded $30,000 in scholarships to 30 high school students from 25 states across the country who submitted essays for AFA’s [...]
Carp Cosmetic Surgery Center Now Offering CoolSculpting®
02/07/2018
The non-surgical body contouring procedure freezes away unwanted fat cells AKRON, Ohio, July 02, 2018 (GLOBE NEWSWIRE) -- Steven S. Carp, MD, of Carp Cosmetic Surgery Center offers patients and the community a non- [...]
Sanofi: Disclosure of trading in own shares
02/07/2018
Attachment Disclosure of trading in own shares (PDF).pdf
Sanofi : Déclaration des transactions sur actions propres
02/07/2018
Pièce jointe Déclaration des transactions sur actions propres (PDF).pdf
Ossur Hf : Transactions in relation to share buyback program
02/07/2018
Announcement no. 42/2018 Reykjavik, 02 July 2018 Transactions in relation to share buyback program On 5 March 2018, Össur hf. initiated a share buy-back program, see Company announcement no. 16/2018. The purpose of the [...]
VALNEVA Announces Significant Progress of its Lyme Disease Vaccine Candidate
02/07/2018
Valneva Announces Significant Progress of its Lyme Disease Vaccine Candidate Nantes, France, July 2, 2018 - Valneva SE ("Valneva" or "the Company"), a fully integrated, commercial stage biotech company focused on [...]
VALNEVA annonce des progrès significatifs pour son candidat vaccin contre la maladie de Lyme
02/07/2018
Valneva annonce des progrès significatifs pour son candidat vaccin contre la maladie de Lyme Nantes, France, 2 juillet 2018 - Valneva SE ("Valneva" ou "le Groupe"), société de biotechnologie dédiée au développement, à [...]
NEOVACS : Reprise de cotation
02/07/2018
Paris et Boston, le 2 juillet 2018 - 17 : 45 pm CEST - Néovacs (Euronext Growth Paris : ALNEV), a demandé à Euronext Paris la reprise de la cotation de son titre (ISIN : FR0004032746), des bons de souscription d'actions [...]
NICOX : Number of voting riights as of June 30, 2018
02/07/2018
Nicox SA Société anonyme with a registered capital of € 29,588,510 Head Office: DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis R.C.S. GRASSE 403.942.642 On July 2, 2018, MONTHLY PUBLICATION OF THE [...]
NICOX : Nombre de droits de vote au 30 juin 2018
02/07/2018
Nicox SA Société anonyme au capital de 29 588 510 euros Siège social : DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis R.C.S. GRASSE 403.942.642 Le 2 juillet 2018, PUBLICATION MENSUELLE DU NOMBRE D' [...]

Pages